MaxCyte Platform > Instruments

MaxCyte offers its platform technology in two scalable transfection systems, the MaxCyte STX and the MaxCyte GT. Both instruments use MaxCyte's proprietary flow electroporation technology to transfect up to 1010 cells in less than 30 minutes in a computer-controlled, sterile environment. The MaxCyte® STX™ leads the way in high performance, high throughput transfection, enabling pre-clinical protein production and awidearray of cost and time effective cell-based assays. The flexibility, scalability and reproducibility of the MaxCyte STX make it the ideal solution for use within drug discovery programs. The MaxCyte® GT™ enables the development of enhanced gene therapy and cell therapeutics by providing unparalleled consistency, scalability, and cell loading transfection efficiencies while avoiding the inherent drawbacks and safety concerns of alternative methods. The MaxCyte GT is a cGMP-compliant, clinical-grade instrument that has received Master File designation with the CBER Division of the U.S. FDA and has been cleared by NIH's RAC and Health Canada.